Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Boehringer Ingelheim and OSE Immunotherapeutics advance clinical development of…
Boehringer Ingelheim and OSE Immunotherapeutics advance clinical development of first-in-class SIRP cancer immunology treatment BI 770371 Ingelheim, Germany and Nantes, France, 3 July 2024– Today Boehringer Ingelheim and OSE Immunotherapeutics SA (OSE), a clinical stage biotech company (ISIN: FR0012127173; Mnemo: OSE), announced that Boehringer will be progressing their first-in-class SIRPα immuno-oncology program into the next phase in clinical development. As part of the program,...
Nasdaq GlobeNewswire
03/07/2024
IVI RMA Global and Lavima Fertility join forces in research in fertility…
Ovarian stimulation is the initial part of assisted reproduction treatments, and it is the phase of infertility treatments in which the least relevant advances have been achieved to date. It is one of the main psychological barriers for women when deciding to begin this path towards motherhood. Many of them are concerned about how this process may affect them physically and emotionally.With the aim of making progress in this field, IVI RMA GLOBAL has signed an exclusive agreement with...
Nasdaq GlobeNewswire
03/07/2024
Operating Room Management Market: Transforming Healthcare with USD 7.5 Billion…
Browse in-depth TOC on "Operating Room Management Market" Browse in-depth TOC on "Operating Room Management Market" 150 - Tables30 - Figures240 - Pages Competitive Landscape and Market Dynamics The operating room management market is highly competitive and trending towards consolidation. Key players include Oracle (Cerner Corporation), Epic Systems Corporation, GE Healthcare, and others. Oracle recently strengthened its position through the acquisition of Cerner,...
PR Newswire
03/07/2024
Exoskeleton Market to Surpass USD 23.6 Billion Valuation by 2031 On the Back of…
Download a detailed overview: Download a detailed overview: https://www.skyquestt.com/sample-request/exoskeleton-market Exoskeleton Market Overview: Segments covered in Exoskeleton Market are as follows: Request Free Customization of this report: https://www.skyquestt.com/speak-with-analyst/exoskeleton-market Powered Exoskeletons to Spearhead Revenue Generation Due to Their High Productivity Powered exoskeletons utilize motorized components and actuators to...
PR Newswire
03/07/2024
Medical Electronics Market worth $15.7 billion by 2029 - Exclusive Report by…
Browse in-depth TOC on "Medical Electronics Market" 120 – Tables70 – Figures260 – Pages Browse in-depth TOC on "Medical Electronics Market" 120 – Tables 70 – Figures 260 – Pages Medical Electronics Market Report Scope: Sensors segment based on components in the medical electronics market to grow with the highest growth rate. The highest surge of growth inmedical electronics is due to sensors, which play a crucial role in improving the functionality and accuracy of a wide...
PR Newswire
03/07/2024
Rosacea Therapeutics Market to Reach a Value of $8.41 Billion, Growing at a CAGR…
The growing adoption of telemedicine and digital healthcare solutions is transforming rosacea treatment, enabling remote consultations, follow-ups, and patient monitoring. These innovations enhance patient compliance and expand access to specialized treatments, particularly in underserved areas. Additionally, ongoing research and development efforts are poised to introduce cutting-edge treatments for rosacea, including novel oral medications, laser technologies, and topical formulations. The...
PR Newswire
03/07/2024
Avicenna.AI secures MDR certification for medical imaging AI portfolio
The MDR was introduced to update the EU's regulations for medical devices, addressing safety issues and the recent emergence of AI tools and software as a medical device (SaMD), which did not exist when the old regulations were created. Ensuring MDR compliance is a critical component of obtaining and maintaining CE-mark status, which allows a device to be freely traded in the EU. The MDR was introduced to update the EU's regulations for medical devices, addressing safety issues and the recent...
PR Newswire
03/07/2024
Invitation: Sobi's Q2 2024 report
The presentation can be followed live here or afterwards on sobi.com. The slides will be made available on sobi.com before the conference call. The presentation can be followed livehere or afterwards on sobi.com. The slides will be made available on sobi.com before the conference call. To participate in the conference call, please use the following dial-in details:Sweden : +46 8 5051 0031United Kingdom : +44 207 107 06 13United States : +1 631 570 56 13 For other countries, please...
PR Newswire
03/07/2024
Evaxion Reinforces Milestone Timeline and Provides Shareholder Update
/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today issued the following letter to shareholders. Dear Fellow Shareholders of Evaxion,The first half of 2024 has been off to a very productive start to the year for Evaxion. We have launched our refined strategy, and we are well positioned for value realization via our three-pronged business model focusing on vaccine target discovery collaborations...
Nasdaq GlobeNewswire
03/07/2024
Neuromod Devices Ltd. Appoints Tom Maher as General Counsel
"I am pleased to announce the appointment of Tom as Neuromod Devices' General Counsel. Tom's extensive background in international business and corporate operations in the life sciences industry will be an invaluable asset to Neuromod Devices as we continue to redefine tinnitus care on a global scale." said Dr. Ross O'Neil, Neuromod Devices Founding CEO. "I am pleased to announce the appointment of Tom as Neuromod Devices' General Counsel. Tom's extensive background in…
PR Newswire
03/07/2024
Consumer goods industry statistics & trends: A US$ 2 trillion opportunity -…
Horizon Databook is the largest market research database with over 1 million data points across 20,000+ markets. The platform is first-in-class and is designed to service a full suite of market research clients. It is a one, five solution platform and includes the following: Horizon Databook is the largest market research database with over 1 million data points across 20,000+ markets. The platform is first-in-class and is designed to service a full suite of market research clients...
PR Newswire
03/07/2024
Animal health market: A high revenue generating industry with revenue crossing…
Horizon has a wide array of animal health topics within its database. Here are the top 10 trending animal health markets: Horizon has a wide array of animal health topics within its database. Here are the top 10 trending animal health markets: About Horizon Databook – The most extensive market research database Horizon Databook is the largest market research database with over 1 million data points across 20,000+ markets. The platform is first-in-class and is designed to service a...
PR Newswire
03/07/2024
Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European…
REGULATED INFORMATION INSIDE INFORMATIONNyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment BankMont-Saint-Guibert, Belgium – July 3, 2024, 12:30pm CET / 6:30am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (“OSA”), today announced that it has signed a €37.5 million loan facility...
Nasdaq GlobeNewswire
03/07/2024
Gupshup and Meta along with Sudan Medical Specialization Board and Shabaka…
This initiative aims to address the urgent healthcare needs of over 800,000 Sudanese refugees who currently have limited access to essential medical services in Egypt and its neighboring countries. By leveraging the chatbot, patients can now connect with healthcare professionals via WhatsApp, making medical assistance more accessible and efficient. This initiative aims to address the urgent healthcare needs of over 800,000 Sudanese refugees who currently have limited access to essential…
PR Newswire
03/07/2024
ZINZINO AB (PUBL): PRELIMINARY SALES REPORT Q2 2024
Revenue in Zinzino's sales markets increased by 24% in the second quarter of 2024 compared with the same period last year and amounted to SEK 481.9 (387.3) million. Total revenues in the Group increased by 24% in the second quarter and amounted to SEK 505.4 (407.9) million. Revenue in Zinzino's sales markets increased by 24% in the second quarter of 2024 compared with the same period last year and amounted toSEK 481.9(387.3) million. Total revenues in the Group increased by 24% in the...
PR Newswire
03/07/2024
Specialty Enzymes Market worth $9.2 billion by 2029 - Exclusive Report by…
Browse in-depth TOC on "Specialty Enzymes Market" Browse in-depth TOC on "Specialty Enzymes Market" 297 – Tables 70 – Figures 306 – Pages Advancements in enzyme engineering have enabled the discovery of newenzymes from natural sources, ensuring their safety and efficacy in various applications. This includes their use in producing specialty pharmaceuticals and in biocatalytic processes. A recent study by theUniversity of Notre Dameresearchers inJanuary 2022emphasized...
PR Newswire
03/07/2024
Cytotoxic Drugs and HPAPI Manufacturing Market worth USD 27.1 Billion to 2031 -…
Cytotoxic drugs and high-potency active pharmaceutical ingredients (HPAPIs) are indispensable in modern medicine, particularly in oncology where targeted therapies are revolutionizing treatment approaches. Cytotoxic drugs specifically target and destroy cancer cells while minimizing harm to healthy tissues, offering significant therapeutic benefits. HPAPIs, known for their extremely low occupational exposure limits and potent effects at minimal doses, require specialized manufacturing processes…
PR Newswire
03/07/2024
Direct Primary Care Market Size to Reach USD 80.4 Billion by 2031- Latest Report…
The Direct Primary Care (DPC) market refers to the sector of the healthcare industry focused on the delivery and consumption of primary care services through a direct payment model between patients and healthcare providers. In DPC, patients typically pay a periodic fee (monthly or annually) to their primary care physician or practice, which covers a wide range of basic medical services. These services often include preventive care, routine check-ups, chronic disease management, urgent care…
PR Newswire
03/07/2024
Olon Group Announces the Acquisition of GTP Bioways Group
GTP Bioways Group is a French company operating as Biotech CDMO (Contract Developing and Manufacturing Organisation), specialising in R&D Services, process development and production of mAbs, enzymes, proteins, nanodrugs, ADCs and F&F. GTP Bioways Group, with multiple locations across France, specializes in delivering comprehensive services to biopharmaceutical companies. From preclinical development to commercial stages, the group focuses on utilizing cutting-edge technologies to...
Nasdaq GlobeNewswire
03/07/2024
Two Belgian hospitals live with Sectra's public cloud service for medical…
One of the main reasons for this shift was the need to streamline operations and enhance collaboration between the two sites. Since 2021, the 23 radiologists and nine trainees of both hospitals have worked together in one single association. Previously, they were unable to work in one environment as they were using two different PACS providers. This made it much harder to collaborate. This need originates from the challenge many hospitals face today of dealing with heavy workloads. One of the...
PR Newswire
03/07/2024
Barrington James Announces Strategic Acquisition of S3 Science Recruitment
Dan Barrington, CEO of Barrington James, stated: "We are thrilled to acquire S3 and expand our Human Capital services in Life Sciences. This acquisition enhances our offerings across Board and Executive partnerships, Permanent Recruitment, Contract Recruitment, Staffing, OSP, and FSP. S3's expertise in Clinical and Pre-Clinical specializations, both on a temporary and permanent basis, will perfectly complement Barrington James' comprehensive Life Science services, from Clinical to…
PR Newswire
03/07/2024
Philips appoints Ling Liu as Chief Region Leader of Philips Greater China
Amsterdam, the Netherlands –Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the appointment of Ms Ling Liu as the Chief Region Leader of Philips Greater China, effective immediately. Ms Liu is now a member of Philips' Executive Committee, reporting to Philips CEO Roy Jakobs. She succeeds Andy Ho, who has decided to retire after a long and successful career. Ms Liu and Mr Ho continue to work together to ensure a smooth handover.“Ling is a...
Nasdaq GlobeNewswire
03/07/2024
Hansa Biopharma to host Q2 2024 interim results conference call
To participate in the telephone conference, please use the dial-in details provided below: To participate in the telephone conference, please use the dial-in details provided below: Sweden : +46-8-1241-0952 United Kingdom : +44-203-7696819 United States : +1 646-787-0157 Participant access code: 765135 The webcast will be available onhttps://hansabiopharma.eventcdn.net/events/half-year-january-june-2024 Contacts for more information:Evan Ballantyne, Chief Financial...
PR Newswire
03/07/2024
Press Release: Dupixent approved in the EU as the first-ever targeted therapy…
Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD First-in-world approval of Dupixent for adults with uncontrolled COPD with raised blood eosinophils based on two landmark phase 3 studies showing Dupixent significantly reduced exacerbations, improved lung function and also improved health-related quality of lifeDupixent is the first new treatment approach for COPD in more than a decade and a new option for approximately 220,000 adults in the EU ...
Nasdaq GlobeNewswire
03/07/2024
Altri Comunicati